Benazepril
규격
86541-75-5CAS 번호
2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acidIUPAC 명칭
C24H28N2O5화학식
424.5 g/mol분자량
benazepril; 86541-75-5; Benazeprilum; Benazeprilum [Latin]; Benazepril Sandoz; Briem; Forteekor; CGS-14824A; Cibacen ws; UDM7Q7QWP8; 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid; C09AA07; CHEBI:3011; 1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(R*,R*))-; DTXSID5022645; Benazeprilum (Latin); 2-[(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; benazapril; benzazepril; 2-((3S)-3-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)acetic acid; 2-((3S)-3-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl)acetic acid; RefChem:54434; DTXCID602645; Benazepril (INN); Benazepril Free base; MFCD00864466; CHEMBL838; 109010-10-8; BENAZEPRIL [INN]; Benazepril, (+/-)-; Benazepril [INN:BAN]; [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; 1H-1-Benzazepine-1-acetic acid, 3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (3S)-; Benazepril (hydrochloride); CGS-14824-A; 2-((S)-3-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid; PX47FSF9B3; UNII-UDM7Q7QWP8; Forteekor [veterinary] (TN); Benazepril (Standard); Spectrum_001922; BENAZEPRIL [MI]; Spectrum2_000482; Spectrum3_001674; Spectrum4_000286; Spectrum5_001546; BENAZEPRIL [VANDF]; BENAZEPRIL [WHO-DD]; SCHEMBL16396; BSPBio_003487; KBioGR_000812; KBioSS_002464; MLS006011854; BIDD:GT0800; SPBio_000343; GTPL6374; orb1705329; SCHEMBL29382644; HSDB 7081; HY-B0093R; KBio2_002457; KBio2_005025; KBio2_007593; KBio3_002707; HY-B0093; BDBM50021153; EBC-27047; STK627447; AKOS005560204; CS-1795; DB00542; BENAZEPRIL [EMA EPAR VETERINARY]; NCGC00165740-01; NCGC00165740-02; NCGC00165740-03; NCGC00165740-04; NCGC00165740-12; [(3S)-3-({(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; 2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid; 86499-21-0; FB171048; SMR000857173; SY028603; SBI-0206744.P001; NS00010378; C06843; D07499; T20921; AB00698518-07; AB00698518_08; AB00698518_09; EN300-6481298; Q592802; BRD-K49807096-003-02-3; BRD-K49807096-003-14-8; BRD-K49807096-003-15-5; BRD-K49807096-003-16-3; (3S)-3-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic Acid; 1H-1-Benzazepine-1-acetic acid, 3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (3R)-rel-; 1H-1-Benzazepine-1-acetic acid, 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (R*,R*)-; 1H-1-Benzazepine-1-acetic acid, 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (R*,R*)-(+/-)-; 2-[(S)-3-[[(S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]amino]-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl]acetic Acid; rel-(3R)-3-[[(1R)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid동의어
